{"id":5792,"date":"2023-04-19T09:22:45","date_gmt":"2023-04-19T08:22:45","guid":{"rendered":"https:\/\/www.scottishmesotheliomanetwork.scot.nhs.uk\/?p=5792"},"modified":"2023-04-19T09:28:43","modified_gmt":"2023-04-19T08:28:43","slug":"nero-trial-recently-launched-in-glasgow","status":"publish","type":"post","link":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/nero-trial-recently-launched-in-glasgow\/","title":{"rendered":"Niraparib Efficacy unResectable MesotheliOma Trial recently launched in Glasgow"},"content":{"rendered":"<p>NERO &#8211; Niraparib Efficacy in patients with unResectable MesotheliOma is a randomised phase II trial of Niraparib versus<br \/>\nactive symptom control in patients with previously treated mesothelioma recently opened in Glasgow.  For more information or to refer a patient please contact Dr Nicola Steel, Consultant in Medical Oncology via the Beatson West of Scotland Cancer Centre.  <\/p>\n","protected":false},"excerpt":{"rendered":"<p class=\"nhsuk-card__description\">NERO &#8211; Niraparib Efficacy in patients with unResectable MesotheliOma is a randomised phase II trial of Niraparib versus active symptom [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":5794,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5792","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-education-events"],"_links":{"self":[{"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/posts\/5792","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/comments?post=5792"}],"version-history":[{"count":3,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/posts\/5792\/revisions"}],"predecessor-version":[{"id":5798,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/posts\/5792\/revisions\/5798"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/media\/5794"}],"wp:attachment":[{"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/media?parent=5792"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/categories?post=5792"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/tags?post=5792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}